急性心肌梗死继发室性心律失常采用胺碘酮的整体疗效分析  

Analysis of Overall Efficacy of Amiodarone in Secondary Ventricular Arrhythmias in Acute Myocardial Infarction

作　　者：金雪玉[1] 

机构地区：[1]吉林省吉林中西医结合医院重症医学科,吉林吉林132012

出　　处：《中国卫生标准管理》2017年第5期87-88,共2页China Health Standard Management

摘　　要：目的分析急性心肌梗死继发室性心律失常采用胺碘酮的整体疗效。方法对照组给予基础治疗及利多卡因,研究组给予基础治疗及胺碘酮。对比两组疗效、心律失常发作频率、不良反应。结果研究组总有效率为91.8%,与对照组的71.3%比较,更具疗效优势(P<0.05)。两组治疗前室性期前收缩及短阵室速发作频率差异无统计学意义(P>0.05),治疗后两组上述心律失常情况发作频率均比治疗前好转(P<0.05),研究组好转幅度更为优异(P<0.05)。两组无不良反应。结论急性心肌梗死继发室性心律失常采用胺碘酮的整体疗效显著,可有效遏制心律失常发作频率,安全性好。Objective To analyze the overall efficacy of amiodarone in patients with secondary ventricular arrhythmia in acute myocardial infarction. Methods The control group was given basic treatment and lidocaine, the study group was given basic treatment and amiodarone. Comparison of two groups of efficacy, arrhythmia frequency, adverse reactions. Results The total effective rate was 91.8% in the study group, and 71.3% in the control group（P 〈 0.05）. Before treatment, there was no significant difference between the two groups in the rate of ventricular premature beats and short ventricular tachycardia （P 〉 0.05）. The frequency of arrhythmia in the two groups was better than that before treatment （P 〈 0.05）, and the improvement rate of the study group more excellent （P 〈 0.05）. There were no adverse reactions in both groups. Conclusion The overall effect of amiodarone in patients with secondary ventricular arrhythmias in acute myocardial infarction is significant, which can effectively curb the frequency of arrhythmia and improve the safety.

关 键 词：急性心肌梗死 室性心律失常 胺碘酮 利多卡因 

分 类 号：R542.22[医药卫生—心血管疾病]